Showing results (1751-1760 of 2,171) with videos related to
Sort By:
Pageof 218
Circulation|August 20, 2003
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trialChristopher B Granger, Kenneth W Mahaffey, W Douglas Weaver, et al.Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trialMichael P Hudson, Paul W Armstrong, William W O'Neil, et al.European Heart Journal|December 3, 2009
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarctionMichael C Tjandrawidjaja, Yuling Fu, Cynthia M Westerhout, et al.American Heart Journal|August 9, 2005
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trialSorin J Brener, A Michael Lincoff, Eric R Bates, et al.European Journal of Heart Failure|January 28, 2014
The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF TrialMustafa Toma, Justin A Ezekowitz, Jeffrey A Bakal, et al.Journal of Interventional Cardiology|September 21, 2007
Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trialsRajendra H Mehta, Adam B Greenbaum, Yuliya Lokhnygina, et al.Dermatology and Therapy|April 18, 2022
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysisJonathan I Silverberg, H Chih-Ho Hong, Jacob P Thyssen, et al.Heart (British Cardiac Society)|May 19, 2009
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?K R Bainey, Y Fu, C B Granger, et al.Dermatology and Therapy|July 30, 2024
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 TrialsApril W Armstrong, Matthias Augustin, Jennifer L Beaumont, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 22, 2022
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021Andreas Pinter, Linda Stein Gold, Adam Reich, et al.Pageof 218